XML 49 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue (Tables)
12 Months Ended
Dec. 31, 2022
Revenue  
Schedule of revenue recognized from collaborative arrangements

Year Ended December 31, 

(In thousands)

2022

2021

2020

Viatris collaboration agreement - Amounts receivable from Viatris

$

48,624

$

43,848

$

43,893

Viatris royalties (Non-US)

30

Total

$

48,654

$

43,848

$

43,893

Schedule of collaborative amounts were recorded in the Company's condensed consolidated statements of operations

Year Ended December 31, 

(In thousands)

    

2022

    

2021

2020

Janssen

$

$

11,425

$

26,426

Other

192

38

38

Total collaboration revenue

$

192

$

11,463

$

26,464

Summary of the reductions to R&D costs related to reimbursement payments

Year Ended December 31, 

(In thousands)

    

2022

    

2021

2020

Viatris

$

6,682

$

2,072

$

1,524

Janssen

5,819

8,554

Total reduction to R&D expense, net

$

6,682

$

7,891

$

10,078